Literature DB >> 11063049

Apoptosis: overview and signal transduction pathways.

D E Bredesen1.   

Abstract

Apoptosis is a form of cell death that is driven by an intrinsic cellular suicide program. The roles of apoptosis and other forms of programmed cell death in neural development, maintenance, and disease states are increasingly being recognized and defined. Therapies directed at the apoptotic program have seen at least some degree of success in animal models of neurodegenerative disease, vascular disease, and traumatic CNS injury. This article describes the signal transduction pathways that mediate apoptosis. Broadly speaking, intrinsic and extrinsic pathways for apoptosis activation may be distinguished, as can be cross-talk between these two. These pathways converge on a system of proteases referred to as "capases" (cysteinyl aspartic proteinases), and modulators exist that multimerize, activate, amplify, or inhibit caspases. Activated caspases are the executioners of the apoptotic program, and carry out this function by cleaving specific cellular substrates. Modulation of this process holds promise as a therapeutic approach in neurotrauma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063049     DOI: 10.1089/neu.2000.17.801

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  19 in total

1.  BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury.

Authors:  Nicole Zangrilli Hoh; Amy K Wagner; Sheila A Alexander; Robert B Clark; Sue R Beers; David O Okonkwo; Dianxu Ren; Yvette P Conley
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

Review 2.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury.

Authors:  A G Yakovlev; K Ota; G Wang; V Movsesyan; W L Bao; K Yoshihara; A I Faden
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 4.  Pharmacological treatment of traumatic brain injury: a review of agents in development.

Authors:  J Hatton
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Protection of mature oligodendrocytes by inhibitors of caspases and calpains.

Authors:  Joyce A Benjamins; Liljana Nedelkoska; Edwin B George
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

6.  THE ROLE OF INTRACELLULAR SODIUM (Na) IN THE REGULATION OF CALCIUM (Ca)-MEDIATED SIGNALING AND TOXICITY.

Authors:  Xian-Min Yu; Bradley R Groveman; Xiao-Qian Fang; Shuang-Xiu Lin
Journal:  Health (Irvine Calif)       Date:  2010

Review 7.  Genetic Variation and Impact on Outcome in Traumatic Brain Injury: an Overview of Recent Discoveries.

Authors:  Alwyn Gomez; Carleen Batson; Logan Froese; Frederick A Zeiler
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-10       Impact factor: 5.081

Review 8.  The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success.

Authors:  Ryan C Turner; Sean C Dodson; Charles L Rosen; Jason D Huber
Journal:  J Neurosurg       Date:  2013-01-18       Impact factor: 5.115

9.  Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats.

Authors:  A J Williams; G Ling; R Berti; J R Moffett; C Yao; X M Lu; J R Dave; F C Tortella
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

10.  A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration.

Authors:  Zubair Ahmed; Anne I Doward; Gareth Pryce; Deanna L Taylor; Jennifer M Pocock; John P Leonard; David Baker; M Louise Cuzner
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.